Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Wednesday, November 26, 2014 10:00:07 AM
bullish
good price action
bullish divergence
$AMRN recent news/filings
## source: finance.yahoo.com
Wed, 19 Nov 2014 18:04:21 GMT ~ AMARIN CORP PLC\UK Financials
read full: http://finance.yahoo.com/q/is?s=amrn
*********************************************************
Wed, 19 Nov 2014 11:12:39 GMT ~ Amarin Corporation plc (AMRN) in Focus: Stock Soars 23.4%
read full: http://finance.yahoo.com/news/amarin-corporation-plc-amrn-focus-111239871.html
*********************************************************
Mon, 17 Nov 2014 14:27:13 GMT ~ Amarin Announces Presentation of MARINE and ANCHOR Analyses at the American Heart Association Scientific Sessions Showing Vascepa(R) Significantly Reduced Remnant-Like Particle Cholesterol in Hypertriglyceridemic Patients
[at noodls] - BEDMINSTER, NJ and DUBLIN, IE -- (Marketwired) -- 11/17/14 -- Amarin Corporation Plc(NASDAQ: AMRN) , a biopharmaceutical company focused on the commercialization and development of therapeutics to improve ...
read full: http://www.noodls.com/view/29A7AEFCF72BE55F94A1DEF33ED3A0C157B7ED1C
*********************************************************
Mon, 17 Nov 2014 14:00:00 GMT ~ Amarin Announces Presentation of MARINE and ANCHOR Analyses at the American Heart Association Scientific Sessions Showing Vascepa(R) Significantly Reduced Remnant-Like Particle Cholesterol in Hypertriglyceridemic Patients
[Marketwired] - Amarin Corporation Plc , a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today the presentation of new data and ...
read full: http://finance.yahoo.com/news/amarin-announces-presentation-marine-anchor-140000397.html
*********************************************************
Fri, 14 Nov 2014 21:43:57 GMT ~ AMARIN CORP PLC\UK Files SEC form 8-K, Other Events
read full: http://biz.yahoo.com/e/141114/amrn8-k.html
*********************************************************
$AMRN charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$AMRN company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/AMRN/company-info
Ticker: $AMRN
OTC Market Place: Not Available
CIK code: 0000897448
Company name: Amarin Corp. Plc
Company website: http://www.amarincorp.com
Incorporated In: United Kingdom
$AMRN share structure
## source: otcmarkets.com
Market Value: $165,609,950 a/o Nov 25, 2014
Shares Outstanding: 135,745,861 a/o Feb 23, 2012
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
$AMRN extra dd links
Company name: Amarin Corp. Plc
Company website: http://www.amarincorp.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/AMRN/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/AMRN/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=AMRN+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=AMRN+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=AMRN+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/AMRN/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/AMRN/news - http://finance.yahoo.com/q/h?s=AMRN+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/AMRN/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/AMRN/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/AMRN/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/AMRN/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/AMRN/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/AMRN/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/AMRN/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/AMRN/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=AMRN+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/AMRN
DTCC (dtcc.com): http://search2.dtcc.com/?q=Amarin+Corp.+Plc&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Amarin+Corp.+Plc
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Amarin+Corp.+Plc&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.amarincorp.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.amarincorp.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.amarincorp.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/AMRN/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/AMRN
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/AMRN/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/AMRN/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/AMRN/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000897448&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/AMRN/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/AMRN/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/AMRN/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/AMRN/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=AMRN&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=AMRN
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/AMRN/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=AMRN+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=AMRN+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=AMRN
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=AMRN
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=AMRN+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/AMRN/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=AMRN+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/AMRN.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=AMRN
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/AMRN/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/AMRN/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/AMRN/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/AMRN/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/AMRN
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/AMRN
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/AMRN:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=AMRN
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=AMRN
$AMRN DD Notes ~ http://www.ddnotesmaker.com/AMRN
Recent AMRN News
- Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA (icosapent ethyl) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp(a) Oxidation Mechanistic Effect of Eicosapentaenoic Acid (EPA) to be Presented at the 60th Annual Europe • GlobeNewswire Inc. • 09/09/2024 11:30:00 AM
- Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ethyl) REDUCE-IT® Subgroup Data and New Mechanistic Insights into Eicosapentaenoic Acid (EPA) to be Presented at European Society of Cardiology (ESC) Congress • GlobeNewswire Inc. • 08/22/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2024 09:30:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 08:54:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 08:54:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 11:05:34 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/31/2024 11:05:26 AM
- Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 07/31/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/29/2024 09:30:08 PM
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Portugal • GlobeNewswire Inc. • 07/17/2024 08:15:00 PM
- Amarin to Report Second Quarter 2024 Financial Results and Host Conference Call on July 31, 2024 • GlobeNewswire Inc. • 07/17/2024 12:00:00 PM
- Amarin Partner EddingPharm Receives Regulatory Approval for VASCEPA® (Icosapent Ethyl) in Mainland China for Cardiovascular Risk Reduction (CVRR) • GlobeNewswire Inc. • 07/08/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 11:30:10 AM
- Amarin Board of Directors Announces CEO Transition • GlobeNewswire Inc. • 06/04/2024 11:30:00 AM
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A. • GlobeNewswire Inc. • 05/28/2024 12:15:23 PM
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM